期刊文献+

乙型肝炎病毒核心区基因变异与细胞免疫 被引量:7

Relationship between the HBV core gene mutation and the cellular immunity in host
原文传递
导出
摘要 目的探讨慢性乙型肝炎患者乙型肝炎病毒(HBV)核心区Leu60Val变异与机体细胞免疫水平的关系. 方法通过流式细胞分析技术(FCM)检测外周血T淋巴细胞亚群,利用酶联免疫吸附试验(ELISA)检测血清细胞因子[干扰素γ(IFN-γ)、肿瘤坏死因子α(TNF-α)和白细胞介素2(IL-2)]水平,采用聚合酶链反应(PCR)扩增HBV DNA C基因区片段,并对PCR产物直接测序. 结果 91例慢性乙型肝炎患者发生Leu60Val变异者19例,变异率为20.9%,随病情加重变异率逐渐增加,以重型肝炎组最高;Val60变异株组IFN-γ、TNF-α水平明显增高(t值分别为2.584、4.766,P<0.01),CD4+ /CD8+比值逐渐升高(t=2.275,P<0.05). 结论 Val60变异株可能通过增加与Ⅰ类人白细胞抗原(HLA-I)的亲和力,或上调HLA-I类分子的表达,从而激活大量的细胞毒性T淋巴细胞释放细胞因子,并同时在肝脏局部发挥免疫效应,提高对宿主的杀伤力. Objective To study the relationship between the mutation of Leu60Val in HBV core region and the cellular immunity in patients with chronic hepatitis B (CHB). Methods HBV DNA C gene mutation was confirmed by polymerase chain reaction (PCR) and sequencing the products directly. The cytokines (IFN- γ , TNF-αand IL-2) levels in serum were measured by enzyme linked immunosorbent assay (ELISA). The distribution of T-lymphocyte subpopula-tions in peripheral blood was detected by flow cytometry (FCM). Results The mutation of Leu60Val was found in 19 out of the 91 CHB patients. With the CHB severity, the mutation rate was getting higher, especially in the severe hepatitis group. The IFN-γ and TNF-α levels were much higher in mutant strain group than those in wild strain group (t = 2.584, 4.766, P < 0.01), so was the ratio of CD4+/CD8+ (t = 2.275, P < 0.05). Conclusion The mutant strain of 60Val may increase affinity to HLA-I molecule, or up-regulate the expression of HLA-I molecule, resulting in the activation of CTL to release the cytokines and cause immune response in liver.
出处 《中华肝脏病杂志》 CAS CSCD 2003年第9期533-535,共3页 Chinese Journal of Hepatology
关键词 乙型肝炎病毒 核心区 基因变异 细胞免疫 T淋巴细胞亚群 Hepatitis B virus Mutation Cytokines T-lymphocyte subpopulations Sequence
  • 相关文献

参考文献9

  • 1郭亚兵,侯金林,戴炜,骆抗先,P. KARAYIANNIS.乙型肝炎病毒中国株全基因参照序列的初步建立[J].中华微生物学和免疫学杂志,1999,19(3):197-200. 被引量:29
  • 2中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14009
  • 3骆抗先.乙型肝炎基础和临床[M].北京:人民卫生出版社,2001.327.
  • 4Ferrari C, Penna A, Bertoletti A, et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol, 1990, 145: 3442-3449.
  • 5Milich DR, McLachlan A, Moriarty A, et al. Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg. J Immunol, 1987, 139: 1223-1231.
  • 6Prezzi C, Casciaro MA, Francavilla V, et al. Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection. Eur J Immunol,2001, 31: 894-906.
  • 7Tomaras GD, Greenberg ML. CD8^+ T cell mediated noncytolytic inhibition of human immunodeficiency virus type I. Front Biosci,2001, 6: 575-598.
  • 8Webster G J, Reignat S, Maini MK, et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms.Hepatology, 2000, 32: 1117-1124.
  • 9Malni MK, Boni C, Lee CK, et al. The role of virus-specific CD8(+)cells in liver damage and viral control during persistent hepatitis B virus infection, J Exp Med, 2000, 191: 1269-1280.

二级参考文献2

  • 1甘人宝 储美瑾 等.克隆的adr亚型乙型肝炎病毒基因(PADR-1)的核苷酸顺序[J].Acta Biochinica et Biophysica Sinica(生物化学与生物物理学报:英文版),1984,16(3):316-319.
  • 2琦祖和 阎捃 等.乙型肝炎病毒adrNC-1 DNA的全顺序测定[J].中国科学:B辑,1988,12:1300-1304.

共引文献14059

同被引文献90

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部